Overview

Global aortic intervention market, which currently stands at $2 billion, still shows signs of robust growth. The market is expected to grow at an average annual growth rate of 6% per year to reach $3 billion in 2020.

Medtronic, Cook, Gore, Endologix and Terumo are currently the top five leading aortic endograft companies and the size of their market share reflects the order in which they have been mentioned.

Not all five companies are present in all anatomical segments of the market, or in all geographical locations for that matter. This represents an intriguing opportunity for consolidation through acquisitions during 2014 and interesting prospects for the many innovative start-ups that are starving for cash in this difficult space.

With 71% share, abdominal aortic stent grafts account for the majority of the market. They experienced a resurgence during the previous three years due to the rollout of new lower profile devices designed to treat a wider universe of patients with tortuous, angulated aortas that were previously not eligible for EVAR.

New generations of devices that further expands the universe of patients eligible for endovascular repair are expected to rollout in major markets with thought leaders predicting that before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly.

The Aortic Intervention Market Report attempts to answer some important questions regarding the fast evolving aortic intervention landscape. The report examines Leading companies technologies, product offerings, market shares and strategic positions. It uncovers areas with maturing trends as well as areas with high growth potential and provides an updated forecast to 2020. Leading companies profiled in the report include Medtronic, Cook Medical, Gore Medical, Endologix, Terumo and TriVascular. Other companies mentioned include Altura, Aptus Endosystems, Bolton Medical, Braile Biomedica, Braun, Cardiatis, Lifetech Scientific, Getinge, Johnson & Johnson, Jotec, Lombard Medical, Microport Medical and Nano Endoluminal. Aortic Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this one billion dollar fast growing market.

Full Product Details

Author:   Medtech Ventures
Publisher:   Createspace Independent Publishing Platform
Imprint:   Createspace Independent Publishing Platform
Dimensions:   Width: 21.60cm , Height: 0.30cm , Length: 27.90cm
Weight:   0.132kg
ISBN:  

9781494897413

ISBN 10:   1494897415
Pages:   46
Publication Date:   03 January 2014
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   In stock  
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Medtech Ventures is a forward looking think tank and virtual startup accelerator specialized in the medical technology industry. Medtech Ventures offers its clients a broad portfolio of services revolving around the concept of Virtual Incubation. Medtech Ventures helps with idea evaluation, opportunity sizing, technology assessment, market analysis as well as perception management and venture capital sourcing and finance. Medtech Ventures also publish brief market insight & niche opportunity reports targeted at senior executives in the medical technology field.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions